 | squibb said not interested in buying cetus | by marjori shaff | reut | new york | jun robert fild | president and chief | execut of cetus corp | told reut that squibb corp | is not interested in buying cetus | earli the compani said squibb would buy from cetus a | fiv pct equity postion in cetus ser about mln dlrs | this is not an attempt by squibb to becom a maj | majority hold in cetus | fild told reut in an interview | squibb haver not approached us with any indication that they | want to acqu us and we wouldn | t be interested in that kind | of arrangement | said fild | squibb could not be reached to comment on the lat comments | by fild | squibb is cetus | first pharmaceutical partn and the only | one to own an equity position in cetus | eastman kodak co | and w | r | grac both hav joint ventur with cetus | but | neith owm an equity position in the company | said fild | cetus haver a ventur with kodak to develp diagnostic | products and with grac to develop agricultural products | earli | squibb and cetus announced in a joint statement | an agreement in principl to form a joint ventur to develop | new biotechnology products in several fields | as part of the deal squibb will licens several of cetus | anticanc agents | including interleukin | in development | squibb will sell the drugs only in japan and other markets but | not in north american and western europ | we wouldn | t hav don this deal had it not been understood | that cetus wants to build its own fully integrated busin in | north amer and europ | said fild | he said squibb was the good partn becaus squibb haver a | maj joint ventur in japan and haver sal capabiliti of its | own in that market | fild said cetus haver shunned licensing arrangements with | pharmaceutical compani becaus it wanted to build its own | busin | many larg corporati hav invested in small | biotech firms | but squibb | s investment in cetus is the first it haver mad | in biotechnology | fild said that was attract to cetus | becaus it wanted a partn that didn | t hav a relationship | with a larg numb of other biotechnology compani | fild said his strategy was to hav partn in non drug | are lik diagnostics and agricultur | but to | keep the | biggest developments in anticanc drugs to ourselv | fild said the partnership with squibb would be used to | broaden the company | s reach in such big money making are | as the cardiovascul | anti infect and the anti inflammatory | markets | squibb is also investming mln dlrs in cetus | research | over the next fiv years | squibb is putting up over mln dlrs in research and | development to mak it happen | whil the equity position part | of the packag is simply to demonstrat the seriousn of this | partnership | said fild | 